News Related to Kenvue

Related coverage linked through entity extraction aliases.

Johnson & Johnson projects about $100.5 billion in 2026 revenue amid litigation and patent headwinds

Apr 11, 2026

Johnson & Johnson said revenue could reach about $100.5 billion at the midpoint in 2026 after 2024 net sales rose 6% to $94.2 billion. The company faces talc litigation, Stelara patent losses and U.S. drug price negotiations.

Johnson & Johnson Invests Over $1 Billion in Cell Therapy Manufacturing Facility in Pennsylvania

Feb 18, 2026

Johnson & Johnson announced a more than $1 billion investment in a next generation cell therapy manufacturing facility in Montgomery County, Pennsylvania, part of the company's $55 billion U.S. investment strategy through early 2029.